Hiromichi Matsuoka Clinical Oncology Society of Australia Annual Scientific Meeting 2018

Abstracts this author is presenting:

• Multi-centre, Randomised, Double-blind, Placebo-controlled Trial of Additive Duloxetine for Cancer-related Neuropathic Pain Refractory to Opioids and Gabapentinoids — Poster Session 2